Pneumococcal pneumonia is a lung infection caused by the bacterium Streptococcus pneumoniae, one of the most common and serious causes of community-acquired pneumonia worldwide. The bacteria live harmlessly in the nose and throat of many healthy people, but when they invade the lower respiratory tract, they can trigger a sudden, severe infection that fills the air sacs of the lungs with fluid and inflammatory cells. It accounts for a significant share of pneumonia cases that send people to the hospital, and it can be life-threatening, particularly for older adults and people with weakened immune systems.
How the Bacteria Spread
Streptococcus pneumoniae spreads through direct contact with respiratory secretions: saliva, mucus, coughing, and sneezing. The bacteria are extremely common. Anywhere from 5% to 90% of healthy people carry them in their nose or throat at any given time, depending on age and setting. Among adults without children in the household, carriage rates sit around 5 to 10%. Among school-aged children, that number jumps to 20 to 60%. Military personnel living in close quarters can have carriage rates of 50 to 60%.
Carrying the bacteria doesn’t mean you’ll get sick. Most carriers never develop symptoms. But carriage is the necessary first step. The serotypes most commonly found in carriers are the same ones most likely to cause disease. When conditions shift, whether from a viral respiratory infection, a weakened immune system, or another trigger, the bacteria can move from the upper airways into the lungs and cause pneumonia.
Symptoms and How It Feels
Pneumococcal pneumonia tends to hit fast. Unlike some respiratory infections that build gradually over days, this one typically starts with an abrupt onset of high fever and shaking chills (sometimes called rigors). Within hours, you may feel dramatically worse than you did that morning.
Other common symptoms include:
- Productive cough that brings up thick, discolored mucus, sometimes with a distinctive rusty color
- Sharp chest pain that worsens when you breathe deeply or cough (called pleuritic chest pain)
- Shortness of breath and rapid breathing
- Rapid heart rate
- Low oxygen levels
- General weakness and malaise
The rusty-colored sputum is a hallmark that clinicians associate with pneumococcal pneumonia specifically, though not everyone produces it. The combination of sudden fever, shaking chills, and sharp breathing-related chest pain is the classic presentation that distinguishes it from the more gradual onset of “walking pneumonia” caused by other organisms.
Who Is Most at Risk
Age is the single biggest risk factor. Adults 65 and older face significantly elevated risk, and that risk keeps climbing with each additional year. An 80-year-old is at considerably higher risk than a 65-year-old. On the other end of the age spectrum, children under 5 are vulnerable, with the youngest children facing the greatest danger.
Chronic medical conditions also increase susceptibility. Heart disease, lung disease, liver disease, and diabetes all raise the odds of developing pneumococcal pneumonia. People with weakened immune systems face the greatest risk of all. This includes those with HIV, organ transplant recipients, people undergoing cancer treatment, and anyone taking medications that suppress immune function. A prior viral respiratory infection, including influenza, can also set the stage by damaging the airways and lowering local immune defenses.
How It’s Diagnosed
Diagnosing pneumococcal pneumonia with certainty is harder than you might expect. A chest X-ray can confirm that pneumonia is present, but it can’t reliably identify which bacterium is responsible. The gold standard for confirmation is growing S. pneumoniae from a blood or fluid sample, but blood cultures come back positive in only 15 to 30% of cases. That means the majority of pneumococcal pneumonia cases are never definitively confirmed by culture.
A urine antigen test can help fill the gap. This rapid test detects a protein from the pneumococcal cell wall, offering results much faster than a culture. However, its sensitivity is lower than initially hoped. While early data suggested high detection rates, more recent studies put the real-world sensitivity at roughly 60 to 65%. A positive result is reliable (specificity runs above 97%), but a negative result doesn’t rule out pneumococcal pneumonia. In practice, many cases are treated based on clinical judgment, the pattern of symptoms, and how the infection responds to antibiotics.
Treatment and Recovery
Antibiotics are the cornerstone of treatment. For most cases of community-acquired pneumonia, doctors start antibiotics before knowing the exact cause, because waiting for culture results could mean dangerous delays. Current guidelines from the American Thoracic Society recommend that outpatients with other health conditions and all hospitalized patients receive antibiotics promptly.
The duration of treatment has shortened over the years. For non-severe cases treated in the hospital or outpatient settings, a course of 3 to 5 days is now considered appropriate if you’re improving and meet markers of clinical stability: fever resolved, heart rate and breathing rate normalized, oxygen levels adequate, and mental status back to normal. For severe cases requiring hospitalization, the recommended course is at least 5 days, again assuming clinical improvement. If a blood test shows a low level of a protein called procalcitonin (suggesting bacterial infection is unlikely or resolving), antibiotics can sometimes be stopped as early as 48 to 72 hours.
One growing concern is antibiotic resistance. Roughly 2 in 5 invasive pneumococcal infections now involve strains that are resistant to at least one antibiotic. This doesn’t mean the infection is untreatable, but it can complicate the choice of medication and may require switching to alternative drugs.
Potential Complications
When pneumococcal pneumonia becomes severe, the infection can spread beyond the lungs or cause structural damage. Possible complications include collapsed lung tissue or airway blockage, lung abscesses (pockets of pus within the lung), and empyema, where infected fluid collects in the space between the lung and the chest wall. Empyema often requires drainage in addition to antibiotics.
The bacteria can also enter the bloodstream, leading to sepsis, a body-wide inflammatory response that can cause organ failure. In some cases, the infection spreads to the lining of the brain (meningitis) or the outer lining of the heart (pericarditis). Pneumococcal meningitis can result in hearing loss or developmental delays, particularly in children.
For older adults, the long-term picture is sobering. Research published in JAMA Internal Medicine found that elderly patients who survived a bout of community-acquired pneumonia had roughly double the risk of dying from a future pneumonia episode compared to peers who had never been hospitalized with pneumonia. When the original infection was specifically caused by S. pneumoniae, that risk was three times higher. Adults over 70 who survived pneumonia faced a mortality risk 3.6 times greater than the general elderly population.
Vaccination and Prevention
Pneumococcal vaccines are the most effective tool for prevention. More than 100 serotypes of S. pneumoniae exist, but a relatively small number cause the majority of serious infections, and current vaccines target those high-risk strains.
For infants and young children, the CDC recommends a 4-dose series of pneumococcal conjugate vaccine (either PCV15 or PCV20), given at 2 months, 4 months, 6 months, and 12 to 15 months of age. This schedule has dramatically reduced invasive pneumococcal disease in children since its introduction.
For adults 50 and older who have never received a pneumococcal conjugate vaccine (or whose vaccination history is unknown), the CDC recommends a single dose of PCV15, PCV20, or PCV21. If PCV20 or PCV21 is used, no additional pneumococcal vaccines are needed. If PCV15 is used, a dose of a second vaccine (PPSV23) is recommended about one year later. Adults 65 and older who previously received an older vaccine (PCV13) along with PPSV23 may benefit from an updated dose of PCV20 or PCV21, based on a conversation with their provider.
Beyond vaccination, the same strategies that reduce any respiratory infection help here: frequent handwashing, avoiding close contact with people who are actively ill, and managing chronic conditions that weaken the immune system. Staying current on influenza vaccination also matters, since flu is a well-established gateway to secondary bacterial pneumonia.